logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anne E. Hammer

glaxosmithkline usa
H指数:31
被引数:3,088
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus

通过器官特异性selen-sledai反应和belimumab治疗改善系统性红斑狼疮患者的SF-36v2和FACIT乏力的生活质量

LUPUS SCIENCE & MEDICINE
IF3.5
2024-05-080
OAAI
Rendas-Baum, Regina; Chen, Wen-Hung; Gairy, Kerry; Anderson, Seth; Henning, Christine; Hammer, Anne; Kosinski, Mark
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data

belimumab在老年SLE患者中的安全性和有效性: 临床试验数据的综合分析结果

LUPUS SCIENCE & MEDICINE
IF3.5
2023-03-242
OAAI
D'Cruz, David; Eriksson, Gina; Green, Yulia; Hammer, Anne; Ji, Beulah; Meizlik, Paige; Roth, David A.
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

贝利木单抗对系统性红斑狼疮器官损害的影响

ARTHRITIS CARE & RESEARCH
IF3.3
2022-08-0422
OA
Urowitz, Murray B.; Aranow, Cynthia; Asukai, Yumi; Bass, Damon L.; Bruce, Ian N.; Chauhan, Deven; Dall'Era, Maria; Furie, Richard; Fox, Norma Lynn; Gilbride, Jennifer A.; Hammer, Anne; Ginzler, Ellen M.; Gonzalez-Rivera, Tania; Levy, Roger A.; Merrill, Joan T.; Quasny, Holly; Roth, David A.; Stohl, William; van Vollenhoven, Ronald; Wallace, Daniel J.; Petri, Michelle
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
ARTHRITIS & RHEUMATOLOGY
IF10.9
2018-06-1552
OAAI
Doria, A.; Stohl, W.; Schwarting, A.; Okada, M.; Scheinberg, M.; van Vollenhoven, R.; Hammer, A. E.; Groark, J.; Bass, D.; Fox, N. L.; Roth, D.; Gordon, D.
SAFETY OF SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A 6-MONTH OPEN-LABEL EXTENSION STUDY
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2017-06-012
PREAI
Doria, A.; Stohl, W.; Schwarting, A.; Scheinberg, M.; Hammer, A.; Kleoudis, C.; Groark, J.; Fox, N. L.; Roth, D.; Bass, D.; Gordon, D.
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
ARTHRITIS & RHEUMATOLOGY
IF10.9
2017-04-07317
OAAI
Stohl, William; Schwarting, Andreas; Okada, Masato; Scheinberg, Morton; Doria, Andrea; Hammer, Anne E.; Kleoudis, Christi; Groark, James; Bass, Damon; Fox, Norma Lynn; Roth, David; Gordon, David
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus Pooled Analyses From the Phase III Belimumab Trials
ARTHRITIS & RHEUMATOLOGY
IF10.9
2016-08-2547
OAAI
van Vollenhoven, Ronald F.; Petri, Michelle; Wallace, Daniel J.; Roth, David A.; Molta, Charles T.; Hammer, Anne E.; Tang, Yongqiang; Thompson, April
RELIABILITY AND SAFETY OF A NOVEL AUTOINJECTOR FOR SELF-ADMINISTRATION OF SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2016-06-010
PREAI
Sheikh, S. Z.; Fox, N. L.; Hammer, A. E.; Struemper, H.; Groark, J.; Roth, D.; Gordon, D.
PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2016-06-011
PREAI
Sheikh, S. Z.; Fox, N. L.; Hammer, A. E.; Struemper, H.; Groark, J.; Roth, D.; Gordon, D.
CORTICOSTEROID USE ACROSS 52 WEEKS OF BELIMUMAB THERAPY IN SLE PATIENTS WITH HIGH DISEASE ACTIVITY: COMBINED ANALYSES FROM THE BLISS TRIALS
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2014-06-010
PREAI
Van Vollenhoven, R.; Petri, M.; Wallace, D. J.; Roth, D.; Molta, C.; Hammer, A.; Tang, T.; Thompson, A.
BASELINE FACTORS THAT PREDICT HIGH BLYS LEVELS (≥ 2 ng/ml) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM THE BLISS TRIALS
ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2014-06-010
PREAI
Roth, D.; Thompson, A.; Tang, T.; Hammer, A.; Molta, C.
Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials

拉莫三嗪随机对照试验中癫痫的突然意外死亡

EPILEPSIA
IF6.6
2012-10-0251
OA
Tomson, Torbjorn; Hirsch, Lawrence J.; Friedman, Daniel; Bester, Nicolette; Hammer, Anne; Irizarry, Michael; Ishihara, Lianna; Krishen, Alok; Spaulding, Theodore; Wamil, Art; Leadbetter, Robert
Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group
NEUROTHERAPEUTICS
IF6.9
2012-01-0145
OAAI
French, Jacqueline A.; Temkin, Nancy R.; Shneker, Bassel F.; Hammer, Anne E.; Caldwell, Paul T.; Messenheimer, John A.
Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy
EPILEPSIA
IF6.6
2009-03-0458
PREAI
Labiner, David M.; Ettinger, Alan B.; Fakhoury, Toufic A.; Chung, Steve S.; Shneker, Bassel; Tatum, William O.; Miller, J. Mitchell; Vuong, Alain; Hammer, Anne E.; Messenheimer, John A.
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view
EPILEPSY RESEARCH
IF2
2008-02-0112
PREAI
Mills, Kenneth C.; Drazkowski, Joseph F.; Hammer, Anne E.; Caldwell, Paul T.; Kustra, Robert P.; Blum, David E.
Depressive symptoms in epilepsy - Prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs
DRUGS
IF14.4
2008-01-0154
PRE
Miller, J. Mitchell; Kustra, Robert P.; Vuong, Alain; Hammer, Anne E.; Messenheimer, John A.
Effects of Lamotrigine on Mood in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms An Open-Label, Multicentre, Prospective Study
DRUGS & AGING
IF3.8
2008-01-0124
PRE
Fakhoury, Toufic A.; Miller, J. Mitchell; Hammer, Anne E.; Vuong, Alain
Double-blind, placebo-con trolled trial of lamotrigine in combination with other medications for neuropathic pain
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
IF3.5
2007-10-0169
OAAI
Silver, Marianne; Blum, David; Grainger, Joanne; Hammer, Anne E.; Quessy, Steve
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study)
EPILEPSIA
IF6.6
2007-09-0634
OAAI
Tompson, Debra J.; Ali, Imran; Oliver-Willwong, Ruth; Job, Sarah; Zhu, Li; Lemme, Francesca; Hammer, Anne E.; Vuong, Alain; Messenheimer, John A.
Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy
NEUROLOGY
IF8.5
2006-08-0890
PREAI
Blum, D.; Meador, K.; Biton, V.; Fakhoury, T.; Shneker, B.; Chung, S.; Mills, K.; Hammer, A.; Isojaervi, J.

研究方向

暂未获取到该数据
D
David A. Roth
H 指数:55论文数:286被引数:2.6万
A
Alain Vuong
H 指数:18论文数:36被引数:907
J
John A. Messenheimer
H 指数:38论文数:121被引数:5,057
J
James Groark
H 指数:13论文数:32被引数:935
R
Ronald van Vollenhoven
H 指数:114论文数:982被引数:7.1万
W
William Stohl
H 指数:55论文数:203被引数:1.3万
D
Damon Bass
H 指数:18论文数:39被引数:2,217
P
Pamela S. Barrett
H 指数:12论文数:23被引数:2,053
M
Michelle Petri
H 指数:136论文数:981被引数:7.3万
A
Andrea Doria
H 指数:104论文数:979被引数:4.2万